AI-powered robotic system now available at CMH for treatment of enlarged prostate
Contact: Sarah Bello
BPH impacts quality of life for millions of men
CMH is expanding its offerings for robotic-assisted surgeries in Astoria. The CMH-OHSU Health Urology Clinic is now offering Aquablation® therapy with the new HYDROS™ Robotic System to treat men suffering from an enlarged prostate (benign prostatic hyperplasia - BPH).
Aquablation therapy, delivered by an AI-powered robotic system, is clinically proven to provide significant, durable BPH symptom relief while preserving sexual function and continence across prostates of all shapes and sizes.
BPH impacts urinary function for millions of men, making it difficult to urinate and fully empty the bladder. Common indicators of BPH are the need to urinate immediately or urgently, urinating more often than normal and urinating frequently at night.
Without timely treatment, BPH can lead to severe health issues, such as permanent bladder or kidney damage, bladder stones and incontinence. One in two men ages 51-60 have BPH1, and 99 percent of men say BPH impacts their quality of life2. The standard treatment option today is surgery, but this has been shown to impact sexual function and continence.
"Benign Prostate Hyperplasia (BPH) is a very common condition that severely compromises the quality of life for many men. When BPH becomes advanced, it can also significantly affect critical kidney functions," says Dr. John Mansfield, board-certified urologist with the CMH-OHSU Health Urology Clinic. " We are very pleased now to offer Aquablation therapy in Astoria so our patients can reclaim their lifestyles with minimal downtime and side effects and find lasting relief from the symptoms and dangers of BPH."
Aquablation therapy is a minimally invasive treatment. What makes it different is that it uses a robotic waterjet system guided by real-time imaging. This system lets doctors create a personalized plan and remove only the prostate tissue causing problems while protecting the areas that control important functions.
The HYDROS Robotic System, now in use at CMH, is the newest advancement in Aquablation therapy. Built on experience from more than 50,000 procedures, HYDROS includes smart AI tools for treatment planning, advanced imaging and robotic precision. It’s designed to make the procedure more efficient, easier in use for surgical teams, and more consistent, leading to better results for patients.
Aquablation therapy is backed by five-year clinical data demonstrating significant symptom relief while preserving sexual function and continence.
Call 503.338.4075 to make an appointment with the CMH-OHSU Health Urology Clinic. For more information on Aquablation therapy, visit aquablation.com.
References:
- Roehrborn, CG, Rosen, RC. Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily. Clinical Interventions in Aging 2008:3(3).
- Data on file at PROCEPT BioRobotics.